YC Companies/Summer 2020/Gilgamesh Pharmaceuticals
Gilgamesh Pharmaceuticals logo

Gilgamesh Pharmaceuticals

Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company…

Summer 2020Healthcare / Healthcare -> Drug Discovery and DeliveryNew York, NY, USA; Remote15 employees
Therapeutics
Psychedelics
Mental Health

About

Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions.

Build your own investing agent

GPAgent keeps YC listings public and neutral. Fund-specific scoring, notes, and workflow state live in each customer workspace.

Join the GPAgent waitlist

Founders (3)

Andrew Kruegel
Founder
Dalibor Sames
Founder
JONATHAN SPORN
Founder

Details

Status
Active
Stage
Early
Team Size
15
Regions
United States of America, America / Canada, Remote, Fully Remote